General Info
Patrick Heron is a General Partner at Frazier Healthcare Partners, focusing on biotechnology. He has led investments in over 20 companies. Patrick’s investments are primarily in the life sciences sector, and he has a track record of successful partnerships with entrepreneurs across various company types and stages. His investment check size ranges from $617 million to $987 million. Some of his previous successful investments include ARMO (acquired by Eli Lilly), Ignyta (acquired by Roche), and Tobira Therapeutics (acquired by Allergan). Patrick’s professional career is marked by his expertise in company formation and leadership on multiple boards in the life sciences field.
Location:
Country: United States of America
Industries: Not available
Investment Regions: EU
Investment Stages: pre-seed, seed
angel-individual
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Search results show Patrick (Pat) Heron has investment activity in Oct 2025 (Tubulis Series C) and Oct 2024 (Alpha9 Theranostics Series C). The most recent identified investment is in October 2025 – which is less than 6 months before the reference date – and includes an investment in Tubulis. Therefore classify as very-active.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of pat heron
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI